HHS - 21 CFR PART 822
|Publication Date:||1 April 2017|
What is the purpose of this part?
The purpose of this part is to implement our postmarket surveillance authority to maximize the likelihood that postmarket surveillance plans will result in the collection of useful data. These data can reveal unforeseen adverse events, the actual rate of anticipated adverse events, or other information necessary to protect the public health.